Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group (Q74352469)
Jump to navigation
Jump to search
scientific article published on 01 September 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group |
scientific article published on 01 September 2000 |
Statements
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group (English)
Tonino RP
Meunier PJ
Emkey R
Rodriguez-Portales JA
Menkes CJ
Wasnich RD
Bone HG
Santora AC
Wu M
Desai R
1 September 2000